Brind.
  1. The World Sleep Congress is being held in Singapore on September 4, 2025, involving Resmed.

Alkermes plans to present research results at the World Sleep Congress in Singapore.

2 reports, 2 independent Updated Aug 25
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Alkermes plans to present research results at the World Sleep Congress in Singapore.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Alkermes will present its research findings at the World Sleep Congress in Singapore.1 source
  2. Alixorexton treatment showed significant improvements in wakefulness for Narcolepsy type 1.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • PR NewswireAlkermes to Present Detailed Positive Results From Vibrance-1 Phase 2 Study Evaluating Alixorexton in Patients With Narcolepsy Type 1 at World Sleep 2025 – Results From Vibrance-1 to Be Shared in Thr
  • BenzingaAlkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study Alkermes plc (NASDAQ:ALKS) on Monday released topline results from the randomized double-blind treatment period of the V